Interferent effect of hydroxyurea on continuous glucose monitoring

Emily D. Szmuilowicz; Grazia Aleppo

doi:10.2337/dc20-3114

Interferent effect of hydroxyurea on continuous glucose monitoring

Emily D. Szmuilowicz^*, Grazia Aleppo

^*Corresponding author for this work

Medicine, Endocrinology Division

Research output: Contribution to journal › Letter › peer-review

14 Scopus citations

Original language	English (US)
Pages (from-to)	e89-e90
Journal	Diabetes care
Volume	44
Issue number	5
DOIs	https://doi.org/10.2337/dc20-3114
State	Published - May 1 2021

Funding

Funding. This work was supported by the Division of Endocrinology, Metabolism and Molecular Medicine at Northwestern University. Duality of Interest. G.A. has served as consultant for Dexcom, Inc., and Insulet Corporation and has received research support from Dexcom, Eli Lilly, and Insulet Corporation. No other potential conflicts of interest relevant to this article were reported. Author Contributions. E.D.S. designed the study and collected the data. E.D.S. and G.A. analyzed the data. E.D.S. and G.A. wrote the manuscript. E.D.S. is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

ASJC Scopus subject areas

Advanced and Specialized Nursing
Internal Medicine
Endocrinology, Diabetes and Metabolism

Access to Document

10.2337/dc20-3114

Cite this

@article{1ca1c1d5d8bd4fb2b96c4128b771bfed,

title = "Interferent effect of hydroxyurea on continuous glucose monitoring",

author = "Szmuilowicz, {Emily D.} and Grazia Aleppo",

note = "Funding Information: Funding. This work was supported by the Division of Endocrinology, Metabolism and Molecular Medicine at Northwestern University. Duality of Interest. G.A. has served as consultant for Dexcom, Inc., and Insulet Corporation and has received research support from Dexcom, Eli Lilly, and Insulet Corporation. No other potential conflicts of interest relevant to this article were reported. Author Contributions. E.D.S. designed the study and collected the data. E.D.S. and G.A. analyzed the data. E.D.S. and G.A. wrote the manuscript. E.D.S. is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.",

year = "2021",

month = may,

day = "1",

doi = "10.2337/dc20-3114",

language = "English (US)",

volume = "44",

pages = "e89--e90",

journal = "Diabetes care",

issn = "0149-5992",

publisher = "American Diabetes Association Inc.",

number = "5",

}

TY - JOUR

T1 - Interferent effect of hydroxyurea on continuous glucose monitoring

AU - Szmuilowicz, Emily D.

AU - Aleppo, Grazia

N1 - Funding Information: Funding. This work was supported by the Division of Endocrinology, Metabolism and Molecular Medicine at Northwestern University. Duality of Interest. G.A. has served as consultant for Dexcom, Inc., and Insulet Corporation and has received research support from Dexcom, Eli Lilly, and Insulet Corporation. No other potential conflicts of interest relevant to this article were reported. Author Contributions. E.D.S. designed the study and collected the data. E.D.S. and G.A. analyzed the data. E.D.S. and G.A. wrote the manuscript. E.D.S. is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

PY - 2021/5/1

Y1 - 2021/5/1

UR - http://www.scopus.com/inward/record.url?scp=85106539716&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85106539716&partnerID=8YFLogxK

U2 - 10.2337/dc20-3114

DO - 10.2337/dc20-3114

M3 - Letter

C2 - 33653823

AN - SCOPUS:85106539716

SN - 0149-5992

VL - 44

SP - e89-e90

JO - Diabetes care

JF - Diabetes care

IS - 5

ER -

Interferent effect of hydroxyurea on continuous glucose monitoring

Funding

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this